Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(50.0%)
N/A
1(50.0%)
2Total
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04628000Completed

Baseline Vitamin D Deficiency and COVID-19 Disease Severity

Role: lead

NCT04120064Phase 1Terminated

Treatment of Vitamin D Deficiency With Large Bolus Cholecalciferol

Role: lead

NCT04450576Unknown

HbA1c as an Early Serologic Marker for the Hemodynamic Progression of Stage A Heart Failure

Role: lead

NCT04129632Not ApplicableCompleted

Evaluation of Institutional Resources and a Novel Mindfulness Tool on Burnout Intensity

Role: lead

All 4 trials loaded